Braunstein Scott
CHAIRMAN AND CEO at MARINUS PHARMACEUTICALS, INC.; SVP, Strategy & Corp. Dev. at PCRX
- Sold, on record
- $226k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 5, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MARINUS PHARMACEUTICALS, INC.CHAIRMAN AND CEO
- PCRXPacira BioSciences, Inc.SVP, Strategy & Corp. Dev.
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MARINUS PHARMACEUTICALS, INC.30,438 shares
- PCRX768 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PCRXPlan not statedJun 5, 2017 2017
Sold 768 shares at $43.32 ($33k)
Braunstein Scott, SVP, Strategy & Corp. Dev.
Sold 7.1% of holdings ($466k position)9,982 shares leftFirst sale on recordFiling
- 2 Form 4 sale MARINUS PHARMACEUTICALS, INC.RoutineAug 8, 2023 +2255 days
Sold 6,443 shares at $9.55 ($62k)
Braunstein Scott, CHAIRMAN AND CEO
10b5-1 planSold 3.9% of holdings ($1.6M position)160,762 shares leftFirst sale on recordFiling
- 3 Form 4 sale MARINUS PHARMACEUTICALS, INC.No planFeb 16, 2024 +192 days
Sold 11,850 shares at $9.94 ($118k)
Braunstein Scott, CHAIRMAN AND CEO
No 10b5-1 planSold 5% of holdings ($2.3M position)223,512 shares leftFiling
- 4 Form 4 sale MARINUS PHARMACEUTICALS, INC.No planAug 5, 2024 +171 days
Sold 12,145 shares at $1.13 ($14k)
Braunstein Scott, CHAIRMAN AND CEO
No 10b5-1 planSold 3.9% of holdings ($351k position)298,667 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Aug 7, 2024 | MARINUS PHARMACEUTICALS, INC. | CHAIRMAN AND CEO | Form 4 sale | 12,145 | $14k | 3.9% | No plan | SEC |
| Feb 16, 2024 | Feb 21, 2024 | MARINUS PHARMACEUTICALS, INC. | CHAIRMAN AND CEO | Form 4 sale | 11,850 | $118k | 5.0% | No plan | SEC |
| Aug 8, 2023 | Aug 8, 2023 | MARINUS PHARMACEUTICALS, INC. | CHAIRMAN AND CEO | Form 4 sale | 6,443 | $62k | 3.9% | Routine | SEC |
| Jun 5, 2017 | Jun 7, 2017 | PCRX | SVP, Strategy & Corp. Dev. | Form 4 sale | 768 | $33k | 7.1% | Plan not stated | SEC |